The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Abstract
Many important decisions on hypertension management must currently be taken without the support of evidence \nfrom large randomized controlled trials. The following issues appear in urgent need to be approached by simply \ndesigned trials. \n(1) Should antihypertensive drugs be prescribed to all patients with grade 1 hypertension, even when total \ncardiovascular risk is relatively low or moderate? Because of the very low rate of cardiovascular events \nexpected in these patients, a placebo-controlled trial using intermediate endpoints such as signs of organ \ndamage of recognized prognostic importance would be feasible, ethical, and clinically relevant. \n(2) Should antihypertensive drugs be prescribed to the elderly with grade 1 hypertension, and should antihypertensive \ntreatment achieve a goal of below 140/90mmHg also in the elderly? These trials could make use \nof hard cardiovascular outcomes and could be placebo-controlled. \n(3) Should antihypertensive drug treatment be started in diabetic patients or in patients with previous cerebrovascular \nor cardiovascular disease when BP is still in the high normal level, and should BP goal be below 130/ \n80mmHg in these patients? These issues can be approached by placebo-controlled trials because no trial \nevidence is still available on the benefit of lowering high normal BP or of achieving BP goals below 130/ \n80mmHg. \n(4) What are the lowest safe BP values to achieve by treatment in different clinical conditions? This issue should \nbe approached by trials comparing more or less intense BP-lowering treatment strategies in patients with \ndifferent cardiovascular risk levels. \n(5) Are lifestyle measures known to reduce BP also capable of reducing morbidity and mortality in hypertension? \nA controlled randomized trial using intermediate endpoints (organ damage) would be feasible and desirable \nin patients with high normal BP or grade 1 hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nakao, N., Yoshimura, A., Morita, H., Takada, M., Kayano, T., & Ideura, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12229-5 · Cited by 970
RetractedChobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citation(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Self-citationLv, J., Neal, B., Ehteshami, P., Ninomiya, T., Woodward, M., Rodgers, A., Wang, H., MacMahon, S., Turnbull, F., Hillis, G., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001293 · Cited by 777
Cooper-DeHoff, R. M., Gong, Y., Handberg, E. M., Bavry, A. A., Denardo, S. J., Bakris, G. L., & Pepine, C. J. (2010) · JAMA · doi:10.1001/jama.2010.884 · Cited by 651
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31821daaf6 · Cited by 614
Self-citationVI Diretrizes Brasileiras de Hipertensão
(2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010001700001 · Cited by 596
Impact of diabetes on cardiovascular disease: an update
Matheus, A. S. D. M., Tannus, L. R. M., Cobas, R. A., Palma, C. C. S., Negrato, C. A., & Gomes, M. D. B. (2013) · International Journal of Hypertension · doi:10.1155/2013/653789 · Cited by 547
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G., Brown, A. S., Ferdinand, K. C., Ann Forciea, M., Frishman, W. H., Jaigobin, C., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.008 · Cited by 514
Self-citationHigh-Sensitivity C-Reactive Protein and Cardiovascular Disease
Yousuf, O., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.016 · Cited by 494
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 426
Self-citationLapi, F., Azoulay, L., Yin, H., Nessim, S. J., & Suissa, S. (2013) · BMJ · doi:10.1136/bmj.e8525 · Cited by 393
Periodontitis is associated with hypertension: a systematic review and meta-analysis
Muñoz Aguilera, E., Suvan, J., Buti, J., Czesnikiewicz-Guzik, M., Barbosa Ribeiro, A., Orlandi, M., Guzik, T. J., Hingorani, A. D., Nart, J., & D’Aiuto, F. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz201 · Cited by 394
Bogdanski, P., Suliburska, J., Szulinska, M., Stepien, M., Pupek-Musialik, D., & Jablecka, A. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.05.007 · Cited by 331
Lv, J., Ehteshami, P., Sarnak, M. J., Tighiouart, H., Jun, M., Ninomiya, T., Foote, C., Rodgers, A., Zhang, H., Wang, H., et al. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121468 · Cited by 305
Metabolic and Vascular Effect of the Mediterranean Diet
Tuttolomondo, A., Simonetta, I., Daidone, M., Mogavero, A., Ortello, A., & Pinto, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194716 · Cited by 269
Lee, H.-Y., Shin, J., Kim, G.-H., Park, S., Ihm, S.-H., Kim, H. C., Kim, K.-I., Kim, J. H., Lee, J. H., Park, J.-M., et al. (2019) · Clinical Hypertension · doi:10.1186/s40885-019-0124-x · Cited by 264
Kones, R. (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 259
Lionakis, N. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i5.135 · Cited by 258
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Parati, G., Lombardi, C., Hedner, J., Bonsignore, M. R., Grote, L., Tkacova, R., Lévy, P., Riha, R., Bassetti, C., Narkiewicz, K., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00226711 · Cited by 227
Self-citationCardiovascular drug therapy in the elderly: benefits and challenges
Fleg, J. L., Aronow, W. S., & Frishman, W. H. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.162 · Cited by 186
Lebeau, J.-P., Cadwallader, J.-S., Aubin-Auger, I., Mercier, A., Pasquet, T., Rusch, E., Hendrickx, K., & Vermeire, E. (2014) · BMC Family Practice · doi:10.1186/1471-2296-15-130 · Cited by 148
Rieck, Å. E., Cramariuc, D., Boman, K., Gohlke-Bärwolf, C., Staal, E. M., Lønnebakken, M. T., Rossebø, A. B., & Gerdts, E. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.194878 · Cited by 129
de Burgos-Lunar, C., Salinero-Fort, M. A., Cárdenas-Valladolid, J., Soto-Díaz, S., Fuentes-Rodríguez, C. Y., Abánades-Herranz, J. C., & del Cura-González, I. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-146 · Cited by 96
Guessous, I., Dobrinas, M., Kutalik, Z., Pruijm, M., Ehret, G., Maillard, M., Bergmann, S., Beckmann, J. S., Cusi, D., Rizzi, F., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds137 · Cited by 70
Bönner, G., Bakris, G. L., Sica, D., Weber, M. A., White, W. B., Perez, A., Cao, C., Handley, A., & Kupfer, S. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.6 · Cited by 61
Renal denervation for treatment of drug-resistant hypertension
Esler, M. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.09.014 · Cited by 55
Blood Pressure Response to Submaximal Exercise Test in Adults
Wielemborek-Musial, K., Szmigielska, K., Leszczynska, J., & Jegier, A. (2016) · BioMed Research International · doi:10.1155/2016/5607507 · Cited by 54
Zeigler, C. C., Wondimu, B., Marcus, C., & Modéer, T. (2015) · BMC Oral Health · doi:10.1186/s12903-015-0026-6 · Cited by 41
Reichert, T., Costa, R. R., Barroso, B. M., da Rocha, V. D. M. B., Delevatti, R. S., & Kruel, L. F. M. (2018) · Sports Medicine · doi:10.1007/s40279-018-0918-0 · Cited by 34
Carlsson, A. C., Nixon Andreasson, A., & Wändell, P. E. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.03.005 · Cited by 26
Petrie (2016) · doi:10.1097/hjh.0000000000000890 · Cited by 20
Left ventricular hypertrophy in Turner syndrome: a prospective echocardiographic study
Mortensen, K. H., Gravholt, C. H., Hjerrild, B. E., Stochholm, K., & Andersen, N. H. (2012) · Echocardiography · doi:10.1111/j.1540-8175.2012.01754.x · Cited by 15
Metadata
- Authors
- Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., Erdine, S., Fagard, R., Farsang, C., Grassi, G., Haller, H., Heagerty, A., Kjeldsen, S. E., Kiowski, W., Mallion, J. M., Manolis, A., Narkiewicz, K., Nilsson, P., Olsen, M. H., Rahn, K. H., Redon, J., Rodicio, J., Ruilope, L., Schmieder, R. E., Struijker-Boudier, H. A. J., Van Zwieten, P. A., Viigimaa, M., & Zanchetti, A.
- Venue
- Blood Pressure
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 18
- Issue
- 6
- Pages
- 308-347
- ISSN
- 0803-7051 (ISSN-L)
- 1651-1999
- OpenAlex
- W1988716175
- Cited by
- 894
- References
- 305
- FWCI
- 88.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.